CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Net sales	$ 1,803,195	$ 1,172,419	$ 3,655,325	$ 2,205,149
Cost of sales (including related party purchases of $98,743 and $96,728 in the three months ended December 31, 2022 and 2021, respectively, and $195,279 and $184,415 in the six months ended December 31, 2022 and 2021, respectively)	1,465,773	1,008,676	2,970,368	1,903,267
Gross Profit	337,422	163,743	684,957	301,882
Research and development	70,700	65,471	144,943	130,614
Sales and marketing	28,445	21,960	57,808	43,584
General and administrative	23,095	25,263	46,901	47,507
Operating Expenses	122,240	112,694	249,652	221,705
Operating Income (Loss)	215,182	51,049	435,305	80,177
Other (expense) income, net	(6,335)	(607)	1,719	(557)
Interest Expense	(1,756)	(1,150)	(5,694)	(1,954)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	207,091	49,292	431,330	77,666
Income tax provision	(29,573)	(7,599)	(68,507)	(10,924)
Share of (loss) income from equity investee, net of taxes	(1,351)	239	(2,240)	627
Net income	176,167	41,932	360,583	67,369
Affiliated
Related party sales	20,073	41,616	45,126	72,538
Related party purchases	$ 98,743	$ 96,728	$ 195,279	$ 184,415